Search

everythinglearnresearchcommunity

for

Search:↓

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Recognizing skin symptoms can help diagnose and manage COVID-19.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Balancing testosterone may reduce COVID-19 severity.

Older age and related diseases increase COVID-19 risk, but anti-aging treatments might help.

Overall alcohol consumption decreased during lockdown, but heavy drinkers consumed more.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

Quality of life improved after COVID-19, but ongoing health support is needed.

More clinical trials are needed to confirm if plant-based products can effectively treat COVID-19.

Sex hormones likely did not affect COVID-19 outcomes in South Korea.

Lower LDL-c levels predict higher COVID-19 mortality.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

Anabolic steroid users may face higher risk of severe COVID-19.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Nailfold dermoscopy is a simple, cheap way to check blood vessel changes in COVID-19 patients.

Certain symptoms and patient profiles, like thoracic pain and general malaise, increase the risk of COVID-19 patients being readmitted to the emergency department.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

The pandemic changed how often certain skin conditions were diagnosed.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Physical activity increased, but sedentary behavior also rose, especially in men.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Accurate diagnosis and personalized treatment are crucial in dermatopathology.

Females generally have stronger immune responses than males due to the X chromosome.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Vaccination helps reduce long COVID symptoms in women with PCOS.